March 29, 2017
TroutTalks KOL Series: 2nd Annual AACR Preview Event
New York, United States
The Trout Group to Host Trout Talk With Marcela V. Maus, MD, PhD of Harvard Medical School and Charles G. Drake, MD, PhD of Johns Hopkins School of Medicine in New York City
April 6, 2016
NEW YORK, NY -- (Marketwired) -- 04/06/16 -- The Trout Group, the leading global investor relations and strategic advisory firm servicing the life sciences industry, today announced an upcoming Trout Talk key opinion leader (KOL) AACR 2016 Preview webcast featuring Marcela V. Maus, MD, PhD of Harvard Medical School and Charles G. Drake, MD, PhD of Johns Hopkins School of Medicine. This preview will highlight select studies being presented at the upcoming 2016 meeting of the American Association for Cancer Research. The Trout Talk will be webcast live on April 6th at 12 pm ET and can be accessed at trouttalk.troutgroup.com.
Trout Talks is an ongoing series featuring conversations with prominent and up-and-coming researchers who are driving scientific innovation forward.
Dr. Maus has performed extensive investigations in the biology of T cell receptors, including the design and manufacture of chimeric antigen receptors, so called CARs, a technology that has already revolutionized the treatment of certain blood cancers.
Dr. Drake's expertise is in the use of checkpoint inhibitors, the immunotherapy agents that have made such an impact in the treatment of certain solid tumors. His work has also recently been focused on the use of radiation in conjunction with checkpoint blockade.
The Trout Talk, moderated by Trout Group scientific advisor Neil Canavan, will consist of a 1 hour presentation by Dr. Maus and Dr. Drake followed by up to 30 minutes of Q&A. Webcast participants can send questions to email@example.com at any time before or during the event; submitted questions will be answered in the order received, and the asker's identity shall remain anonymous.
About The Trout Group:
The Trout Group is a global investor relations and strategic advisory firm. Since 1996, Trout has been a leading strategic partner to the life sciences industry, connecting companies, the capital markets and innovations in the sector. Trout's unique suite of services at the intersection of scientific advances and a network of institutional relationships creates long term value for stakeholders.
For general inquires please contact:
Source: The Trout Group LLC